ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,523Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 2456

$648K Total Retail Price of All Prescriptions

Rank: 130 out of 2456

404 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 10,860 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 549 459 1 2
LISINOPRIL 486 453 2 1
LEVOTHYROXINE SODIUM 445 428 3 4
FUROSEMIDE 370 352 4 8
OMEPRAZOLE 352 220 5 3
CITALOPRAM HBR 293 281 6 14
WARFARIN SODIUM 292 281 7 9
AMLODIPINE BESYLATE 291 262 8 5
HYDROCODONE-ACETAMINOPHEN 291 178 S3 8 20
METOPROLOL TARTRATE 284 279 10 10
ATORVASTATIN CALCIUM 269 260 11 12
ATENOLOL 240 204 12 6
TRAZODONE HCL 221 186 13 17
POTASSIUM CHLORIDE 210 204 14 33
MIRTAZAPINE 207 198 15 29
HYDROCHLOROTHIAZIDE 203 196 16 7
ISOSORBIDE MONONITRATE ER 198 198 17 48
METOPROLOL SUCCINATE 179 170 18 13
GABAPENTIN 172 142 19 16
FAMOTIDINE 151 140 20 84
RISPERIDONE 147 130 21 50
PANTOPRAZOLE SODIUM 138 114 22 37
NAMENDA 136 134 23 42
METFORMIN HCL ER 130 112 24 59
LOSARTAN POTASSIUM 124 114 25 18
OXYCODONE-ACETAMINOPHEN 122 49 S2 26 35
KLOR-CON M20 116 107 27 69
DONEPEZIL HCL 113 113 28 23
LACTULOSE 105 22 29 88
TRAMADOL HCL 102 67 30 24
PRAVASTATIN SODIUM 101 80 31 15
LOVASTATIN 100 88 32 34
FLOVENT HFA 98 85 33 104
ALENDRONATE SODIUM 94 84 34 19
SPIRIVA 94 68 34 43
DIGOXIN 94 90 34 49
RANITIDINE HCL 92 80 37 31
METFORMIN HCL 92 77 37 11
ALLOPURINOL 90 78 39 27
CYMBALTA 87 73 40 65
SERTRALINE HCL 83 61 41 21
FLUTICASONE PROPIONATE 70 59 42 30
LAMOTRIGINE 66 57 43 120
PROAIR HFA 64 45 44 22
CLOPIDOGREL 62 62 45 55
LIPITOR 62 59 45 63
DILTIAZEM 24HR CD 61 61 47 113
PREDNISONE 61 59 47 39
VERAPAMIL ER 60 46 49 91
OXYCODONE HCL 60 50 S2 49 38
IBUPROFEN 59 21 51 52
CELEBREX 57 57 52 127
CRESTOR 56 47 53 25
IPRATROPIUM-ALBUTEROL 55 41 54 85
CARBIDOPA-LEVODOPA 54 54 55 82
NIFEDIPINE ER 54 54 55 61
DIOVAN 53 53 57 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 42 58 147
DIVALPROEX SODIUM 50 42 59 51
DILTIAZEM 24HR ER 50 50 59 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.